Stockreport

Immunovant to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Immunovant, Inc.  (IMVT) 
PDF NEW YORK, Jan. 03, 2024 (GLOBE NEWSWIRE) -- Immunovant, Inc. (Nasdaq: IMVT), a clinical-stage immunology company dedicated to enabling normal lives for people with aut [Read more]